Preventing Recurrent Urinary Tract Infections With α-D-mannose
Status:
Terminated
Trial end date:
2020-05-31
Target enrollment:
Participant gender:
Summary
In this trial, women with history of recurrent urinary tract infections (UTIs) will be
followed over the course of 6 months. The women will be randomized either to D- Mannose or
Placebo.
The primary objective of this study is to investigate if treatment with D-mannose reduces the
risk for a UTI recurrence compared to treatment with Placebo.
H0: Women with history of recurrent UTIs treated with D-Mannose on average have the same
number of recurrent UTIs over the course of 6 months compared to women treated with Placebo.
H1: Women with history of recurrent UTIs treated with D-Mannose on average have fewer
recurrent UTIs over the course of 6 months compared to women treated with Placebo.